Active ingredient
Ruxolitinib NDC Codes
Ruxolitinib is an active ingredient in 10 finished products listed with the FDA, under 2 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Labelers
- Incyte Corporation
- Strengths
- Ruxolitinib 11 mg/1; Ruxolitinib 22 mg/1; Ruxolitinib 33 mg/1; Ruxolitinib 44 mg/1; Ruxolitinib 55 mg/1; Ruxolitinib 5 mg/1; Ruxolitinib 10 mg/1; Ruxolitinib 15 mg/1; Ruxolitinib 20 mg/1; Ruxolitinib 25 mg/1
- Dosage forms
- Tablet, Extended release, Tablet
- Routes
- Oral
- Drug classes (FDA established)
- Janus Kinase Inhibitor, Kinase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 11
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Jakafi XRruxolitinib | Ruxolitinib 11 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-011 | 50881-0011-08 | — |
| Jakafi XRruxolitinib | Ruxolitinib 22 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-022 | 50881-0022-08 | — |
| Jakafi XRruxolitinib | Ruxolitinib 33 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-033 | 50881-0033-08 | — |
| Jakafi XRruxolitinib | Ruxolitinib 44 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-044 | 50881-0044-08 | — |
| Jakafi XRruxolitinib | Ruxolitinib 55 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-055 | 50881-0055-08 | — |
| Jakafiruxolitinib | Ruxolitinib 5 mg/1 | TabletOral | Incyte Corporation | 50881-005 | 50881-0005-60 | — |
| Jakafiruxolitinib | Ruxolitinib 10 mg/1 | TabletOral | Incyte Corporation | 50881-010 | 50881-0010-0150881-0010-60 | — |
| Jakafiruxolitinib | Ruxolitinib 15 mg/1 | TabletOral | Incyte Corporation | 50881-015 | 50881-0015-60 | — |
| Jakafiruxolitinib | Ruxolitinib 20 mg/1 | TabletOral | Incyte Corporation | 50881-020 | 50881-0020-60 | — |
| Jakafiruxolitinib | Ruxolitinib 25 mg/1 | TabletOral | Incyte Corporation | 50881-025 | 50881-0025-60 | — |
Ruxolitinib: common questions
- Which drugs contain Ruxolitinib?
- Jakafi XR, Jakafi.
- Is there a J-code for Ruxolitinib?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.